Cancer cell DNA damage via ionizing radiation

"Cancer cell DNA damage via ionizing radiation" does not refer to a specific molecular target, receptor, enzyme, transporter, or protein. Instead, it describes the biological process by which exposure of cancer cells to ionizing radiation leads to various forms of nuclear and mitochondrial genetic lesions, including base modifications, single-strand breaks (SSBs), double-strand breaks (DSBs), clustered/complex lesions, crosslinks with proteins and other macromolecules. The most lethal form is generally considered DSBs—especially complex DSBs—which can overwhelm cellular repair mechanisms and lead either to apoptosis/cell death or mutagenesis if misrepaired. Ionizing radiation induces these effects both directly—by depositing energy into the chemical bonds within the nucleic acids—and indirectly—by generating reactive oxygen species that further attack cellular components including nucleotides and sugar moieties within the backbone structure. The biological consequences depend on dose and type of irradiation; high linear energy transfer sources produce more complex clustered damages that are harder for cells' repair machinery to resolve successfully. The clinical relevance lies in exploiting these vulnerabilities therapeutically through radiotherapy while minimizing collateral injury by targeting differences between tumor versus normal tissue responses—for example by inhibiting key repair pathways selectively active in tumors using radiosensitizer drugs like PARP inhibitors. Conversely, excessive unrepaired/misrepaired damage can also drive carcinogenesis if occurring in healthy tissues exposed during therapy. Because "cancer cell DNA damage via ionizing radiation" is a process rather than an individual molecule, it should not be classified as a canonical drug target per se. It represents an important mechanistic endpoint exploited by several classes of anti-cancer therapies but does not fit standard nomenclature conventions for molecular targets.

Other names

Radiation-induced DNA damage in cancer cellsIonizing radiation–induced DNA lesionsIR-induced DNA damage

Not applicable for this entry directly. For radiosensitizers: Inhibit repair pathways such as homologous recombination or nonhomologous end joining, increasing sensitivity to radiation; Enhance generation of reactive oxygen species. For radioprotectors: Scavenge free radicals to reduce indirect DNA damage.